SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies. (2023)
Attributed to:
Phase 1 COVID-19 Data and Connectivity – National Core Study (Phase 1 D&C-NCS)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41579-022-00809-7
PubMed Identifier: 36307535
Publication URI: http://europepmc.org/abstract/MED/36307535
Type: Journal Article/Review
Volume: 21
Parent Publication: Nature reviews. Microbiology
Issue: 2
ISSN: 1740-1526